NYU Vaccine and Treatment Evaluation Unit
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)
This NYU program runs clinical trials that test new vaccines and treatments for infectious diseases like HIV/AIDS and respiratory infections for people who might benefit.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11249990 on NIH RePORTER |
What this research studies
As a patient, you would visit the NYU VTEU clinic to take part in clinical trials of new vaccines and treatments for infections such as HIV and airway viruses. The unit is part of a national NIAID network and works with other sites and leadership to design and run studies and share data. Participants may give blood or other samples, receive study vaccines or medicines, and come for scheduled clinic visits and follow-up. Trials can include both adults and children and range from early safety studies to larger effectiveness studies.
Who could benefit from this research
Good fit: Ideal candidates are people with or at risk for infectious diseases (including HIV/AIDS and respiratory infections) or healthy volunteers eligible for vaccine studies, as defined by each study's criteria.
Not a fit: People with medical conditions unrelated to infectious disease, or who do not meet specific trial eligibility rules, are unlikely to benefit or be eligible.
Why it matters
Potential benefit: If successful, the work could produce safer or more effective vaccines and treatments that prevent or reduce illness from HIV, influenza, and other infectious diseases.
How similar studies have performed: Other sites in the NIAID VTEU network have run successful vaccine and treatment trials, although targets like HIV and a universal flu vaccine remain challenging.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Kottkamp, Angelica Cifuentes — New York University School of Medicine
- Study coordinator: Kottkamp, Angelica Cifuentes
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.